The early detection of schizophrenia is a hot topic in psychiatry. If we could detect schizophrenia during the “prodromal” phase, before overtly psychotic symptoms became problematic, perhaps early intervention could prevent or delay the onset of full-blown schizophrenia.
SSRIs are the mainstay of medication treatment for social anxiety disorder (SAD), while cognitive behavior therapy (CBT) is at least as effective. Oddly, combined SSRI and CBT treatment has not clearly outperformed each treatment alone in controlled trials. But a new study implies that MAOIs combined with CBT may be particularly effective.
While drug companies have been working hard to come up with new options for the treatment of dementia, there have been no new FDA approvals since memantine (Namenda) hit the scene in 2003.
Let’s assume that you have already diagnosed a patient with Alzheimer’s Disease (AD). Your patient has received a full workup to rule out medical causes, has had a full battery of neuropsychological tests, and you have started a standard cocktail of whichever cholinesterase inhibitor you prefer.
The frequency of antidepressant induced mania has been elusive, with some studies finding high rates of manic switching and others finding very few or no manic episodes among patients taking antidepressants.